Latest Earnings Results: Q2 '26
Estimated EPS
-$0.24
Reported EPS
-$0.27
Surprise
-10.96%
Estimated Rev
$7.88M
Reported Rev
$8.05M
Surprise
+2.27%
• Reported GAAP EPS of -$0.27 • Reported revenue of $8.05M up 10.91% YoY • Rapid Micro Biosystems is reaffirming its full year 2026 total revenue guidance range of $37.0 million to $41.0 million, including 30 to 38 Growth Direct system placements and gross margins of 20%.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.20 | -- | -- | N/A |
Q2 '26 | -$0.24 | -$0.27 | -10.96% | MISSED |
Q1 '26 | -$0.25 | -$0.31 | -25.68% | MISSED |
Q4 '25 | -$0.23 | -$0.28 | -23.53% | MISSED |
Q3 '25 | -$0.25 | -$0.26 | -6.12% | MISSED |